Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells
Authors:
- 23 February 2022
- journal article
- letter
- Published by Springer Nature in International Journal of Hematology
- Vol. 115 (4) , 605-608
Abstract
No abstract availableFunding Information
- Japan Society for the Promotion of Science (# 20K08763, #17K09940)
- Japan Agency for Medical Research and Development (#15lm0103010j0002, #16lm0103010j0003)
- Japanese Society of Hematology Research Grant
This publication has 3 references indexed in Scilit:
- Expression of activated integrin β7 in multiple myeloma patientsInternational Journal of Hematology, 2021
- Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myelomaBlood, 2021
- The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapyNature Medicine, 2017